.AstraZeneca has discussed an early consider the functionality of its own internal antibody-drug con...
.After announcing a phase 3 launch based upon beneficial midstage end results, iTeos as well as GSK ...
.The FDA needs to be actually much more available and collaborative to discharge a rise in approvals...
.It's an unusually busy Friday for biotech IPOs, with Zenas BioPharma, MBX as well as Bicara Rehabs ...
.Atea Pharmaceuticals' antiviral has actually fallen short an additional COVID-19 trial, yet the bio...
.Neurocrine Biosciences' schizophrenia program pivot has actually fallen short. The biotech was actu...
.Sanofi has actually made an overdue entry to the radioligand party, paying for one hundred million ...
.After F2G's 1st try to acquire a brand-new class of antifungal to market was actually derailed due ...
.Moderna has actually vowed to cut R&D spending by $1.1 billion through 2027. The decision to ret...
.Only 4 months after Sanofi bet $80 million in beforehand cash on Key Therapies' losmapimod, the pla...